Creation of a prognostic index for spine metastasis to stratify survival in patients treated with spinal stereotactic radiosurgery: Secondary analysis of mature prospective trials

International Journal of Radiation Oncology Biology Physics

Volumn 93, Issue 1, 2015, Pages 118-125

  Tang, Chad ^a   Hess, Kenneth ^a   Bishop, Andrew J ^a   Pan, Hubert Y ^a   Christensen, Eva N ^a   Yang, James N ^a   Tannir, Nizar ^a   Amini, Behrang ^a   Tatsui, Claudio ^a   Rhines, Laurence ^a   Brown, Paul ^a   Ghia, Amol ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; PATHOLOGY; PATIENT MONITORING; REGRESSION ANALYSIS; SURGERY;

DISEASE BURDENS; METASTATIC DISEASE; METHODS AND MATERIALS; OVERALL SURVIVAL; PERFORMANCE STATUS; SPINAL METASTASIS; SPINE METASTASIS; STEREOTACTIC RADIOSURGERY;

DIAGNOSIS;

ADULT; AGED; ARTICLE; BRIEF PAIN INVENTORY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURVIVAL; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MD ANDERSON SYMPTOM INVENTORY; OVERALL SURVIVAL; PAIN; PRIORITY JOURNAL; PROGNOSTIC INDEX FOR SPINAL METASTASIS; PROSPECTIVE STUDY; RACE; SCORING SYSTEM; SPINE METASTASIS; STEREOTACTIC RADIOSURGERY; STEREOTACTIC SPINE RADIATION SURGERY; VERY ELDERLY; ANALYSIS OF VARIANCE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; MIDDLE AGED; MORTALITY; PAIN MEASUREMENT; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RADIATION DOSE; RADIOSURGERY; SECONDARY; SPINAL NEOPLASMS; SURVIVAL; THEORETICAL MODEL; TIME; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PAIN MEASUREMENT; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; SPINAL NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; YOUNG ADULT;

EID: 84939466367     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.04.050     Document Type: Article

References (30)

1. P.E. Kaloostian, A. Yurter, P.L. Zadnik, and et al. Current paradigms for metastatic spinal disease: An evidence-based review Ann Surg Oncol 21 2014 248 262
2. A.K. Garg, A.S. Shiu, J. Yang, and et al. Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases Cancer 118 2012 5069 5077
3. M.R. Folkert, M.H. Bilsky, A.K. Tom, and et al. Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine Int J Radiat Oncol Biol Phys 88 2014 1085 1091
4. D.E. Heron, M.S. Rajagopalan, B. Stone, and et al. Single-session and multisession cyberknife radiosurgery for spine metastases - University of Pittsburgh and Georgetown University experience J Neurosurg Spine 17 2012 11 18
5. R. Foster, J. Meyer, P. Iyengar, and et al. Localization accuracy and immobilization effectiveness of a stereotactic body frame for a variety of treatment sites Int J Radiat Oncol Biol Phys 87 2013 911 916
6. R. Harel, and L. Zach Spine radiosurgery for spinal metastases: Indications, technique and outcome Neurol Res 36 2014 550 556
7. A. Sahgal, E.G. Atenafu, S. Chao, and et al. Vertebral compression fracture after spine stereotactic body radiotherapy: A multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score J Clin Oncol 31 2013 3426 3431
8. A. Sahgal, V. Weinberg, L. Ma, and et al. Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice Int J Radiat Oncol Biol Phys 85 2013 341 347
9. M. Guckenberger, F. Mantel, P.C. Gerszten, and et al. Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: A multi-institutional analysis Radiat Oncol 9 2014 226
10. F. Mantel, S. Glatz, A. Toussaint, and et al. Long-term safety and efficacy of fractionated stereotactic body radiation therapy for spinal metastases Strahlenther Onkol 190 2014 1141 1148
11. X.S. Wang, L.D. Rhines, A.S. Shiu, and et al. Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: A phase 1-2 trial Lancet Oncol 13 2012 395 402
12. Y. Tokuhashi, H. Kawano, S. Ohsaka, and et al. [A Scoring System For Preoperative Evaluation of the Prognosis of Metastatic Spine Tumor (a Preliminary Report)] Nihon Seikeigeka Gakkai Zasshi 63 1989 482 489
13. Y. Tokuhashi, H. Uei, M. Oshima, and et al. Scoring system for prediction of metastatic spine tumor prognosis World J Orthop 5 2014 262 271
14. D. Rades, S. Douglas, T. Veninga, and et al. Validation and simplification of a score predicting survival in patients irradiated for metastatic spinal cord compression Cancer 116 2010 3670 3673
15. D. Rades, J. Dunst, and S.E. Schild The first score predicting overall survival in patients with metastatic spinal cord compression Cancer 112 2008 157 161
16. S.T. Chao, S.A. Koyfman, N. Woody, and et al. Recursive partitioning analysis index is predictive for overall survival in patients undergoing spine stereotactic body radiation therapy for spinal metastases Int J Radiat Oncol Biol Phys 82 2012 1738 1743
17. T. Sheu, J.V. Heymach, S.G. Swisher, and et al. Propensity score-matched analysis of comprehensive local therapy for oligometastatic non-small cell lung cancer that did not progress after front-line chemotherapy Int J Radiat Oncol Biol Phys 90 2014 850 857
18. I. Fumagalli, J.E. Bibault, S. Dewas, and et al. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases Radiat Oncol 7 2012 164
19. T.S. Armstrong, J.S. Wefel, M. Wang, and et al. Net clinical benefit analysis of Radiation Therapy Oncology Group 0525: A phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma J Clin Oncol 31 2013 4076 4084
20. B.J. Barney, X.S. Wang, C. Lu, and et al. Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer Qual Life Res 22 2013 2143 2150
21. F. Efficace, C. Cartoni, P. Niscola, and et al. Predicting survival in advanced hematologic malignancies: Do patient-reported symptoms matter? Eur J Haematol 89 2012 410 416
22. S. Halabi, N.J. Vogelzang, A.B. Kornblith, and et al. Pain predicts overall survival in men with metastatic castration-refractory prostate cancer J Clin Oncol 26 2008 2544 2549
23. E.L. Chang, A.S. Shiu, M.F. Lii, and et al. Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases Int J Radiat Oncol Biol Phys 59 2004 1288 1294
24. A.S. Shiu, E.L. Chang, J.S. Ye, and et al. Near simultaneous computed tomography image-guided stereotactic spinal radiotherapy: An emerging paradigm for achieving true stereotaxy Int J Radiat Oncol Biol Phys 57 2003 605 613
25. C.S. Cleeland, and K.M. Ryan Pain assessment: Global use of the brief pain inventory Ann Acad Med Singapore 23 1994 129 138
26. T.S. Armstrong, I. Gning, T.R. Mendoza, and et al. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module J Neurosurg Spine 12 2010 421 430
27. M. D'Angelica, M.F. Brennan, J.G. Fortner, and et al. Ninety-six five-year survivors after liver resection for metastatic colorectal cancer J Am Coll Surg 185 1997 554 559
28. Y. Fong, A.M. Cohen, J.G. Fortner, and et al. Liver resection for colorectal metastases J Clin Oncol 15 1997 938 946
29. K. Decaestecker, G. De Meerleer, and F. Ameye Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP): Study protocol for a randomized phase II trial BMC Cancer 14 2014 671
30. J.L. Lopez Guerra, D. Gomez, Y. Zhuang, and et al. Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis Int J Radiat Oncol Biol Phys 84 2012 e61 e67